News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
55 Results
Type
Article (4)
Press Release (51)
Section
Business (25)
Deals (2)
FDA (3)
News (30)
Policy (1)
Tag
Alliances (11)
Approvals (3)
Diagnostics (4)
Earnings (5)
Events (2)
FDA (3)
Medical device (1)
Medtech (1)
Mergers & acquisitions (2)
NextGen: Class of 2025 (1)
People (7)
Regulatory (1)
Startups (2)
Date
2023 (1)
2022 (1)
2021 (1)
2018 (3)
2017 (4)
2016 (2)
2015 (1)
2012 (9)
2011 (7)
2010 (4)
Location
Asia (2)
Europe (36)
55 Results for "ipsogen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
QIAGEN Wins FDA Nod for First-Ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms
The approval is for its ipsogen JAK2 RGQ PCR Kit for additional use in the diagnosis of all MPNs.
January 23, 2018
·
1 min read
Business
TrovaGene, Inc., Achieves Intellectual Property Milestone Under License Agreement with Ipsogen
August 29, 2012
·
5 min read
Deals
QIAGEN Inc. Plans to Buy Cancer MDx Firm Ipsogen for $101 Million
June 15, 2011
·
10 min read
Deals
QIAGEN N.V. Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics
July 11, 2011
·
6 min read
Ipsogen Reinforces its Leadership in Molecular Diagnosis and Monitoring of Leukemia
January 12, 2009
·
2 min read
Business
Ipsogen Confirmation of Strong Growth Over the First Half of 2008
August 1, 2008
·
1 min read
FDA
Ipsogen Announces the CE Marking of its “ProfileQuant(R) WT1" Kit
March 16, 2009
·
2 min read
Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting
July 10, 2009
·
4 min read
Business
Ipsogen Consolidates its Position in North America and Appoints Susan Hertzberg President
September 3, 2008
·
2 min read
Ipsogen Announces Three Studies at the American Society of Clinical Oncology Meeting
May 19, 2008
·
5 min read
1 of 6
Next
